Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venus Medtech (Hangzhou) Inc. is set to hold its 2024 Second Class Meeting for holders of unlisted foreign shares on December 5, 2024, in Hangzhou, China. The meeting aims to discuss and approve proposed amendments to the company’s articles of association and Rule 2.07A. Shareholders are encouraged to attend and vote on these significant resolutions.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.